关注
Michael Miller, MD
Michael Miller, MD
Professor of Medicine, Hospital of the University of Pennsylvania
在 pennmedicine.upenn.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
cannon cp
6611*2004
Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia
DL Bhatt, PG Steg, M Miller, EA Brinton, TA Jacobson, SB Ketchum, ...
New England Journal of Medicine 380 (1), 11-22, 2019
29412019
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association
M Miller, NJ Stone, C Ballantyne, V Bittner, MH Criqui, HN Ginsberg, ...
Circulation 123 (20), 2292-2333, 2011
23392011
Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association
FM Sacks, AH Lichtenstein, JHY Wu, LJ Appel, MA Creager, ...
Circulation 136 (3), e1-e23, 2017
14832017
Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events
B Pitt, RP Byington, CD Furberg, DB Hunninghake, GBJ Mancini, ...
Circulation 102 (13), 1503-1510, 2000
12582000
Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives
WS Harris, M Miller, AP Tighe, MH Davidson, EJ Schaefer
Atherosclerosis 197 (1), 12-24, 2008
8692008
A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection
TI Pollin, CM Damcott, H Shen, SH Ott, J Shelton, RB Horenstein, W Post, ...
Science 322 (5908), 1702-1705, 2008
8532008
Extended-release niacin or ezetimibe and carotid intima–media thickness
AJ Taylor, TC Villines, EJ Stanek, PJ Devine, L Griffen, M Miller, ...
New England Journal of Medicine 361 (22), 2113-2122, 2009
8302009
Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial
M Miller, CP Cannon, SA Murphy, J Qin, KK Ray, E Braunwald, ...
Journal of the American College of Cardiology 51 (7), 724-730, 2008
8292008
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data
C Reactive Protein Coronary Heart Disease Genetics Collaboration
Bmj 342, 2011
6752011
Cardiovascular efficacy and safety of bococizumab in high-risk patients
PM Ridker, J Revkin, P Amarenco, R Brunell, M Curto, F Civeira, ...
New England Journal of Medicine 376 (16), 1527-1539, 2017
6602017
Statin safety and associated adverse events: a scientific statement from the American Heart Association
CB Newman, D Preiss, JA Tobert, TA Jacobson, RL Page, LB Goldstein, ...
Arteriosclerosis, thrombosis, and vascular biology 39 (2), e38-e81, 2019
6122019
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ...
The Lancet 393 (10184), 1937-1947, 2019
5062019
Comparative molecular analysis of gastrointestinal adenocarcinomas
Y Liu, NS Sethi, T Hinoue, BG Schneider, AD Cherniack, F Sanchez-Vega, ...
Cancer cell 33 (4), 721-735. e8, 2018
4902018
Driver fusions and their implications in the development and treatment of human cancers
Q Gao, WW Liang, SM Foltz, G Mutharasu, RG Jayasinghe, S Cao, ...
Cell reports 23 (1), 227-238. e3, 2018
4862018
International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina
E Topol, R Califf, F Van de Werf, R Diaz, E Paolasso, P Aylward, J Simes, ...
Circulation 97 (24), 2386-2395, 1998
4311998
Characterization of myocardial injury in patients with COVID-19
G Giustino, LB Croft, GG Stefanini, R Bragato, JJ Silbiger, M Vicenzi, ...
Journal of the American College of Cardiology 76 (18), 2043-2055, 2020
3972020
Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association
AC Skulas-Ray, PWF Wilson, WS Harris, EA Brinton, PM Kris-Etherton, ...
Circulation 140 (12), e673-e691, 2019
3972019
Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types
M Seiler, S Peng, AA Agrawal, J Palacino, T Teng, P Zhu, PG Smith, ...
Cell reports 23 (1), 282-296. e4, 2018
3822018
High-density lipoproteins: a consensus statement from the National Lipid Association
PP Toth, PJ Barter, RS Rosenson, WE Boden, MJ Chapman, M Cuchel, ...
Journal of clinical lipidology 7 (5), 484-525, 2013
3752013
系统目前无法执行此操作,请稍后再试。
文章 1–20